Delivery Order SPE2DB22D3301-SPE2DB25FY2CP
Award Date
3/24/25
Potential Completion Date
3/25/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,336.53, is for the delivery of 4,566,294,418 units of Methotrexate 2.5 mg tablets, a medication used to treat various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor in the United States. The contract is for the delivery of 4,565,633,861 units of 2.5 mg methotrexate tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,294.93 and an ultimate completion date of August 30, 2024. This contract is not a set-aside and is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,379,519 units of Methotrexate 2.5 mg tablets. The $1,210.26 firm fixed-price delivery order has an ultimate completion date of August 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,563.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4,565,634,382 units of Methotrexate 2.5 mg tablets. The contract has a completion date of August 30, 2024 and is a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award, valued at $1,160.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the delivery of 4,561,622,675 units of Methotrexate 2.5 mg tablets. The award has an ultimate completion date of July 28, 2023 and is structured as a Firm Fixed Price Delivery Order, with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,843,623 units of Methotrexate 2.5 mg tablets. The $3,853.16 firm fixed-price award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of September 18, 2024 and does not use a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Methotrexate 2.5 mg tablets. The delivery order has a ceiling value of $1,906.78 and an ultimate completion date of September 11, 2024. The contract is a firm-fixed price type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support the healthcare needs of military treatment facilities and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,015.22 Firm Fixed Price contract is for the delivery of 4,560,862,883 units of Methotrexate 2.5 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,971.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,143,768 units of methotrexate 2.5 mg tablets, a medication used to treat various medical conditions. The contract is a firm-fixed-price delivery order with a performance period extending through May 6, 2025. Amerisourcebergen Drug Corp is also the holder of...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of 4,563,434,966 units of methotrexate 2.5 mg tablets in 100-count packages, with a potential value of $1,147.14. The contract has a performance period ending on January 25, 2024. No set-aside designation was used for this...